International Clinical Trial: Real-Time Breath Analysis in Acute Myeloid Leukaemia for a Rapid Characterisation of Biological Subtypes and to Predict Therapy Responses

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826897) titled 'Real-Time Breath Analysis in Acute Myeloid Leukaemia for a Rapid Characterisation of Biological Subtypes and to Predict Therapy Responses' on Sept. 9.

Study Type: Observational

Primary Sponsor: Jeremy Deuel

Condition: AML

Recruitment Status: Not recruiting

Date of First Enrollment: September 21, 2026

Target Sample Size: 120

Countries of Recruitment: Switzerland

To know more, visit https://clinicaltrials.gov/study/NCT07826897

Published by HT Digital Content Services with permission from Health Daily Digest....